Madison-based life science company Mirus Bio to be acquired for $600 million
Mirus Bio, a manufacturer of transfection regents used in gene therapies, has entered into an agreement to be acquired.
Source: biztimes.com
Stay updated with breaking news from Milliporesigma Process Solutions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mirus Bio, a manufacturer of transfection regents used in gene therapies, has entered into an agreement to be acquired.